Finland· FI-REL-REL9195
Asasantin Retard
A thrombozytenaggregationshemmer, exkl. heparin, kombinationen product containing dipyridamole + acetylsalicylic acid, registered in Finland by Boehringer Ingelheim International GmbH. The same ATC class is registered in 10 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Thrombozytenaggregationshemmer, exkl. heparin, kombinationen is registered in 10 of 19 countries.
Countries holding a registration under ATC B01AC30 (thrombozytenaggregationshemmer, exkl. heparin, kombinationen), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 7 of them publish a price we can compare per daily dose
Thrombozytenaggregationshemmer, exkl. heparin, kombinationen · ATC B01AC30
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
The record
At a glance
Fimea (Finland)- Active substance
- Dipyridamole + Acetylsalicylic acid
- Manufacturer
- Boehringer Ingelheim International GmbH
- Country
- Finland (FI)
- ATC code
- B01AC30
- ATC class
- Thrombozytenaggregationshemmer, exkl. Heparin, Kombinationen
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
24 interactions on record for thrombozytenaggregationshemmer, exkl. heparin, kombinationen.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Thrombozytenaggregationshemmer, exkl. heparin, kombinationen · interactions on record
24 records
24 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Thrombozytenaggregationshemmer, exkl. heparin, kombinationen in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesAspirin and DipyridamoleDr. Reddy's Laboratories Inc
- United KingdomAsasantin Retard capsulesDowelhurst Ltd
- NetherlandsDipyridamol/Acetylsalicylzuur Sandoz 200/25 mg, capsules met gereguleerde afgifte, hardSandoz B.V.
- NorwayDiprasorinOrion Corporation - Espoo
- SwedenDiprasorin 200 mg/25 mg Kapsel med modifierad frisättning, hårdOrion Corporation
Authorised across Europe · EMA
The same active substance is authorised in 5 EEA countries. Names it is sold under:
- Denmark · Orisantin
- United Kingdom (Northern Ireland) · Svelux
- Netherlands · Dipyridamol/Acetylsalicylzuur Sandoz
- Norway · Diprasorin
- Sweden · Diprasorin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e09309dd-e662-49da-96f6-464f7bed0158 GET /v1/drugs/e09309dd-e662-49da-96f6-464f7bed0158?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "2",
"form": "säädellysti vapauttava kapseli, kova",
"route": null,
"ddd_unit": "ED",
"strength": null,
"atc_label": "yhdistelmävalmisteet",
"ma_number": "12633",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL9195",
"authorised_at": "1998-03-09"
}See everything about thrombozytenaggregationshemmer, exkl. heparin, kombinationen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.